Background. Both endothelin receptor type B ([ET B R], a G protein-coupled receptor that mediates the vascular effects of the potent vasoconstrictor endothelin-1) and human cytomegalovirus ([HCMV], a ubiquitous herpesvirus) have been implicated in the pathogenesis of cardiovascular disease (CVD). The effects of HCMV infection on ET B R expression are unknown. We hypothesized that HCMV may contribute to the pathogenesis of CVD via ET B R modulation.
hosts is usually mild but can be fatal in immunocompromised individuals such as in acquired immune deficiency syndrome patients or organ transplant patients. It is also the main viral etiological agent responsible for congenital diseases in newborns [1] . Besides being a prominent opportunistic pathogen, and based on evidence accrued to date, HCMV may have a plausible active role in a number of different diseases, such as in cardiovascular diseases (CVDs), cancers, and autoimmune or chronic inflammatory diseases [3, 4] .
For the probable role of HCMV in CVD, we and others have not only showed the high prevalence of HCMV in carotid plaques but also have begun to elucidate the possible multifaceted ways of HCMV in modulating atherogenesis [5] [6] [7] [8] [9] [10] [11] [12] . For example, we recently proposed that HCMV may perturb nitric oxide (NO) production via up-regulation of arginase II, a metalloenzyme that shares the same substrate as endothelial NO synthase and with a potential to mediate endothelial dysfunction [8] . Endothelial cells (ECs) that line the blood vessels are crucial in angiogenesis, a complex process of forming new vessels from pre-existing blood vessels. As such, endothelial dysfunction is the cardinal feature of CVD, especially in ischemic CVD, and it is believed to be responsible for the failure of "therapeutic angiogenesis", which is a promising strategy for the use of proangiogenic growth factors to promote the development of collateral blood vessels [13] .
Endothelin receptor type B (ET B R) is a 7-transmembrane G protein-coupled receptor that mediates the vascular effects of endothelin-1 (ET-1), which is a potent vasoconstrictor [14] . It is predominantly expressed in ECs but can also be detected in vascular smooth muscle cells (SMCs) and other cell types [14, 15] . The ET B R is located in the plasma membrane, cytosol, nucleoplasm, and the nuclear envelope membrane [14] , and its functions depend on the effector cell type. In ECs, ET B R primarily mediates vasodilation by releasing prostacyclin and NO. In SMCs, ET B R instead acts as a vasoconstrictor [14] , similar to endothelin receptor type A (ET A R), which mediates vasoconstriction in vascular SMCs [16] . In addition, ET B R also functions as a "clearance receptor" for ET-1 [17] .
Substantial evidence indicates a crucial role for ET B R in vascular homeostasis. The deregulation of ET B R is associated with CVDs such as coronary artery disease, cerebral ischemia, and atherosclerosis [14, 15] . In addition, mutations in the ET B R gene have been linked to certain genetic diseases [18, 19] . In cancer patients, overexpression of ET B R is associated with melanoma progression [20] and poor prognosis in breast cancer patients [21] , and, consequently, its specific antagonist, BQ-788, has been evaluated as a potential cancer treatment [22] .
Given the role of HCMV in atherogenesis and the importance of ET B R in vascular biology, we hypothesized that HCMV may promote CVD by inducing ET B R. To our knowledge, this is the first study to examine the effects of HCMV on ET B R and functional consequences after ET B R blockade.
METHODS

Virus and Cells
The virus stock, virus titration, and cells used in this study were as described previously [8] . In brief, a plaque-purified HCMV strain VR1814 propagated in human umbilical vein cells (HUVECs) was used as virus stock. The source and growth conditions for HUVEC, human pulmonary arterial SMCs (hPASMCs), and human aortic SMCs (hSMCs) were as described previously [8] . For the flow adhesion assay, HUVECs from 3 different donors were isolated and cultured in complete endothelial basal medium (EBM)-2 medium supplemented with EGM-2 SingleQuots (hereafter referred to as complete EBM-2 medium) instead of M199 as described in the protocol [23] . The use of HUVECs from a healthy donor was approved by the Karolinska Institutet Ethnical Committee (reference number 2012/654-31/3).
Virus Infection and Ganciclovir Treatment
At the indicated times, cells were infected with different multiplicity of infection (moi) of HCMVs, lysed, and RNA was isolated. Both ultraviolet (UV)-inactivation protocol and ganciclovir (GCV) treatment were performed as described previously [8] .
Quantitative TaqMan Polymerase Chain Reaction
The RNA isolation, cDNA synthesis, and TaqMan polymerase chain reaction assay were performed as described previously [8] . The primers and probes (all obtained from Applied Biosystems; Life Technologies, Thermo Fisher Scientific Corporation) were as follows: ET A R (EDNRA, Hs00609865_m1), ET B R (EDNRB, Hs00240747_m1), and IE (custom made with sequence as described in [24] ). The human β 2 -microglobulin (Hs00984230_m1) was used for normalization, and the 2 −ΔΔCT method was used to quantify the relative expression.
Flow Cytometry Analysis
Flow cytometry was performed as described previously [8] . Single-color staining was performed using primary mouse anti-ET B R (1:200; a gift from Dr. Tomoko Doi, Kyoto University) [25] or mouse anti-IE (1:300) (MAB810R; Millipore). For dual staining, cells were incubated with rabbit anti-ET B R (1:200) (AER-002; Alomone Labs) for 30 minutes at room temperature and then washed and fixed with Reagent A followed by permeabilization with Reagent B (Molecular Probes; Invitrogen, Life Technologies) along with primary mouse anti-IE according to the manufacturer's protocol. The positivity was revealed using secondary antibody swine anti-rabbit (1:100) (F0054; Dako) conjugated to fluorescein isothiocyanate isomer 1 or goat anti-mouse (1:100) (R0480; Dako) conjugated to R-phycoerythrin (RPE).
Immunofluorescence and Immunohistochemical Staining
The immunofluorescence (IF) was performed on ice-cold absolute acetone/methanol (1:1) fixed cells in 8-chamber slides as previously described [8] . Primary antibodies used in this study were as follows: mouse anti-HCMV-IE (1:500), rabbit anti-ET B R (1:500), mouse anti-giantin (1:300) (clone G1/133, marker for Golgi; Enzo Life Sciences), and endoplasmic reticulum marker PDI (1:300) (clone 1D3; Enzo Life Sciences), with secondary antibody goat anti-mouse or goat anti-rabbit conjugated to Alexa Fluor 488 or 594 (both from the Molecular Probes and used at 1:500 dilution). For double-immunofluorescent staining, a mixture of indicated primary antibodies was incubated before incubation with corresponding secondary antibodies.
For the immunohistochemical (IHC) staining on frozen carotid plaque tissue sections, a previously used protocol was applied [7] . Primary antibodies were mouse monoclonal anti-HCMV-IE (1:500), mouse monoclonal anti-human Von Willebrand factor (1:50) (Clone F8/86; Dako), and rabbit anti-ET B R (1:250); immunoreactivity was revealed with chromogen 3,3'-Diaminobenzidine. The omission of primary antibody or corresponding isotype antibody served as negative control. Twenty carotid plaques were randomly selected from our previously described biobank, the Biobank of St. Petersburg Investigation of Carotid Endarterectomies [7] . The use of human materials in this study was approved by the Ethical Committee of St. Petersburg State Pavlov Medical University, the Russia Federation. The immunoreactivity was graded as previously described [7] . The wound healing assay was performed using a 6-well plate with 90% confluent HUVECs as described in the Wallert and Provost lab's Wound Assay Protocol (http://web.mnstate.edu/ provost/woundAssayProtocol.pdf ). In brief, cells were gently washed after scratch of HUVEC monolayers and replaced with 2 mL complete EBM-2 medium containing the ET B R blocker with or without HCMV. Pictures were acquired with Olympus CKX 41 inverted microscope using a 4× objective lens at an indicated time.
Angiogenesis: Tube Forming Assay
The assay was performed using angiogenesis µ-slides (lbidi, cat. human umbilical vein cells/well in 50 µL complete EBM-2 medium were seeded in triplicate with or without the presence of ET B R blocker or with or without the HCMV in a final concentration of 100 µM. Tube formation was monitored at indicated times, and images were taken with Olympus CKX 41 inverted microscope.
Isolation of Human Leukocyte
The isolation was performed by a double gradient density centrifugation using Histopaque 1077 and 1119 (both from SigmaAldrich) with anticoagulated EDTA-whole blood, as described previously [26] .
Flow Adhesion Assay
The assay was performed as described previously [26, 27] with the use of ibiTreat µ-slide VI 0.4 (ibidi GmbH). The details of instrument setup, recording, and analysis was performed as described in [28] . In brief, approximately 4 × 10 4 human umbilical vein cells/ chamber were seeded and treated with BQ788 (100 µM) in the presence or absence of HCMV for 16 hours before the assay. All HUVECs were pretreated with 2 ng/mL tumor necrosis factor α (TNF-α) (R&D Systems, cat.no. 210-TA-005) for 2 hours, except for the untreated cells before the assay. At least 6-10 images of each condition were taken for the analysis.
Statistical Analysis
Results were expressed as mean ± standard deviation and analyzed with a Student's t test (version 11.0 software; SigmaPlot) and compared with the uninfected or untreated group. A P < .05 was considered to be statistically significant.
RESULTS
Human Cytomegalovirus Induces Up-Regulation of Endothelin Receptor Type B in Both Endothelial Cells and Smooth Muscle Cells
We infected ECs (HUVEC) and SMCs (hPASMC and hSMC) with a different moi of HCMV and quantified the relative expression of ET B R mRNA at 1, 3, and 5 days of postinfection (dpi) for HUVEC and hPASMC and at 3 and 5 dpi for hSMC. We found that HCMV up-regulated the ET B R mRNA expression in both ECs and SMCs ( Figure 1A .i-A.iii). A similar upregulation of ET B R mRNA was observed in hPASMC, but to a lesser extend in hSMC ( Figure 1A .ii and A.iii, respectively). As expected, viral IE mRNA was increased over time after infection and was moi-dependent ( Figure Figure 1B .i-B.iii), paracrine effects of cytokine(s) were excluded. To determine the viral gene mediating the ET B R up-regulation, we infected and treated HUVECs with GCV that inhibits CMV DNA replication and L gene expression but not expression of IE or E genes [29] . The GCV treatment did not abrogate the induction of ET B R transcripts but instead significantly induced higher expression of ET B R (Figure 2 ), suggesting that viral IE or E gene products are responsible for effect. We tested both siRNAs against the well-characterized IE1-72 or IE2-86, which we did not observe any effects on the ET B R mRNA expression (Supplementary Figure S2) . Taken together, HCMV induced both ET B R mRNA and protein expression most likely via its IE or E proteins.
Human Cytomegalovirus Alters the Cellular Distribution of Endothelin Receptor Type B (ET B R) and Induces ET B R Surface Expression
Endothelin receptor type B is known to be expressed at the plasma membrane, in the cytosol, at the nuclear envelope membrane, and in the nucleoplasm [14] . Consistent with this, we detected ET B R mainly close to the plasma membrane and/or in the cytoplasm but very little in the perinuclear membrane or in the nucleus of the uninfected HUVECs ( Figure 3A , top row). We were surprised to find that HCMV infection resulted in strong expression of ET B R in the cytoplasm ( Figure 3A , bottom row, panel ET B R, arrow) and colocalized with a Golgi marker (giantin) with little or no colocalization in the endoplasmic reticulum ( Figure 3B ).
To determine whether HCMV infection also induces surface expression of ET B R, we compared surface expression on uninfected and infected ECs and SMCs by flow cytometry analysis. As depicted in Figure 3C (left panel), the ET B R surface expression was increased over time after HCMV infection in HUVECs ( Figure 3C , column panel of moi = 0.5 and 5); this effect was moi-dependent, which was consistent with the data for induced mRNA expression ( Figure 3C, right panel) . Very little or no induction of ET B R surface expression was noted in HUVEC treated with UV-irradiated virus, suggesting that viral replication is required for this effect ( Figure 3D , top row of the left panel). Ultraviolet treatment was considered effective because little or no IE protein expression was detected ( Figure 3D , bottom row). Similar ET B R induction was noted in both hPASMC and hSMC ( Figure 3E , bottom row) but not in cells treated with UV-irradiated virus ( Figure 3E , middle row).
We did not detect any ET A R expression with the commercial HUVECs (unpublished data), which is in line with previous studies [30] . However, we did detect low ET A R mRNA expression (threshold of cycle [Ct] = 34) in freshly isolated primary HUVEC from healthy donor, which is in line with what has been reported previously [31] . This allowed us the opportunity to investigate both ET A R and ET B R expression upon HCMV infection in HUVECs. We detected a balanced effect between ET A R and ET B R upon HCMV infection, at least in the early stage of infection (1 dpi to 3 dpi); when there was a reduction of ET B R expression, ET A R was induced at 3 dpi (Supplementary Figure S3) . It is interesting to note that both receptors were up-regulated at 5 dpi when infected with HCMV (MOI = 10). In contrast to the ET B R induction, HCMV caused significantly reduced levels of ET A R expression in both hPASMC and hSMC ( Figure 3F-G) .
Human Cytomegalovirus and Endothelin Receptor Type B Expression Colocalizes in Atherosclerotic Plaques
To examine whether ET B R was present in carotid atherosclerotic plaques ex vivo and whether the virus was colocalized with ET B R, we performed IHC and IF on 20 frozen sections from carotid endarterectomy biopsies obtained from patients. We found that 80% (16 of 20) of the plaques showed immunoreactivity to HCMV-IE antigens; the majority of them, 62.5%, were grade I and 37.5% were grade II (see Supplementary Table S1 ). Endothelin receptor type B was expressed in 80% of the examined plaques and localized to ECs, SMCs, and macrophages/ foam cells. We observed no apparent correlation between percentage of IE and ET B R-positive cells (Supplementary , whereas x-axis is SS Lin. The effects of HCMV on ET A R mRNA level in smooth muscle cells, hPASMC (F) and hSMC (G) (MOI; biological replicates, n = 3 with technical duplicates for each polymerase chain reaction; values are mean ± standard deviation; P < .05 was considered to be statistically significant; *P = .01-.05; **P = .001-.01; ***P < .001). Figure 4A and B). Using IF, we observed distinctly enhanced ET B R expression levels in the nucleus and cytoplasm primarily in HCMV-infected cells ex vivo ( Figure 4B ).
Endothelin Receptor Type B Blockade Reduces Cell Growth and Impairs Tumor Necrosis Factor-α-Mediated Leukocyte Recruitment
Because we observed that HCMV is capable of modulating ET A R or ET B R expression in vitro and observed colocalization of HCMV and ET B R in atherosclerotic plaques, we wondered about the physiological relevance of ET B R on ECs functions. Hitherto, the role of ET B R in ECs, besides the well known cardiovascular effects, remains obscure. Endothelial cells were chosen for further studies due to their critical role in HCMV pathogenesis [32] and because ET B R, but not ET A R, was expressed on the HUVECs used in this study. We first examined the effects of an ET B R blocker, BQ788, on ECs proliferation, migration, and angiogenesis by MTT, wound healing, and tube formation assays, respectively. BQ788 did not affect ECs proliferation, migration, or angiogenesis at 1-day treatment ( Figure 5A-C) , but it resulted in slightly retarded cell growth at 4 days compared with that of untreated cells ( Figure 5A ).
Given that the crucial role of ECs in leukocyte recruitment is fundamental during inflammatory responses [33] , we further examined the effect of BQ788 on leukocyte recruitment to ECs using a flow adhesion assay. To do this, we seeded ECs and activated them with TNF-α in the presence or absence of BQ788. As expected, little or no leukocyte recruitment was recorded in the "nonactivated" HUVECs, whereas leukocytes were recruited Values are mean ± standard deviation; P < .05 was considered to be statistically significant; *P = .01-.05; **P = .001-.01; ***P < .001).
upon TNF-α activation ( Figure 5D ). Treatment with BQ788 significantly reduced TNF-α-mediated leukocyte recruitment ( Figure 5D ), implying a role of ET B R in leukocyte recruitment.
The Effects of Human Cytomegalovirus Infection on Endothelial Cells Proliferation, Migration, and Angiogenesis
Having shown a potential "physiological" role of ET B R in ECs, we next addressed the question of how HCMV modulates these processes. To this end, we infected HUVECs with or without BQ788 and assayed its effects on cellular proliferation, migration, or tube formation. Treatment of BQ788 significantly reduced ECs proliferation at 3 dpi, compared with that of untreated cells (Figure 6A) ; HCMV infection enhanced the inhibitory effect by BQ788 on cellular proliferation ( Figure 6A) . The viral infection (moi = 1) was not cytotoxic to the cells at 3 dpi ( Figure 6A ). Human CMV infection alone or in the presence of BQ788 abolished the migratory properties of ECs in the wound healing assay ( Figure 6B ) as well as its capacity to form tubes in the tube formation assay ( Figure 6C ). The antimigratory and antiangiogenic effect of the HCMV was dependent on the virus load, and, once executed, the effect sustained even after 7 dpi (unpublished observations). In the flow adhesion assay, BQ788 reduced leukocyte Values are mean ± standard deviation; P < .05 was considered to be statistically significant; *P = .01-.05; **P = .001-.01; ***P < .001).
recruitment to infected and TNF-α-stimulated HUVECs (Figure 6D) . Taken together, these findings suggest that HCMV blunts the migratory and angiogenic properties of ECs.
DISCUSSION
It is well accepted that increased ET B R expression in ECs denotes vasodilation via release of NO and prostaglandins, whereas upregulation of ET B R in SMCs is expected to mediate vasoconstriction [14, 34] . In the present study, we found that HCMV affects the expression of both ET B R and ET A R. On one hand, our finding that HCMV increases ET B R in ECs suggests a possible vasoprotective role or the prevention of ECs apoptosis [35] . The antiapoptotic effects mediated by ET B R may favor viral survival in the early stage of viral replication [36] . Thus, in view of current knowledge, up-regulation of ET B R in ECs would promote vasodilation and also enhanced depletion of ET-1 due to its clearance properties [17] . Human CMV also appears to reduce leukocyte recruitment and prevents angiogenesis and migration, which may impair the repair functions after myocardial infarction and result in increased heart damage [37] . On the other hand, up-regulation of ET B R in SMCs might lead to vasoconstriction, proliferation, inflammation, and increased oxidative stress that underlies the pathogenesis of many CVD [14, 34] . Furthermore, the ET B R-induced vascular SMCs proliferation would favor viral growth and survival and contribute to vascular pathogenesis; eg, intima hyperplasia. However, because we also observed a down-regulation of ET A R in SMCs, the net functional effect attributed by HCMV infection via altered ET receptors expression remains unclear. Therefore, further studies are needed to understand the biological net effects of HCMV infection on both ECs and SMCs in terms of vasoconstriction or vasodilation in vivo, but this will be complicated due to the lack of a suitable animal model for HCMV.
It is interesting to note that blockade of ET B R by BQ788 alone or in the presence of HCMV significantly reduced TNF-α-mediated leukocyte recruitment, suggesting a plausible role of ET B R in leukocyte recruitment and inflammation. Leukocyte recruitment includes a cascade of stepwise events that culminates in leukocyte transmigration, with the aid and concrete effort of certain chemoattractants, selectins, and integrins on the ECs (reviewed in [33] ). BQ788 has been shown to suppress up-regulation of TNF-α and rescued retinal ganglion cells from optic nerve injury by attenuating inflammation [38] . The mechanism by which ET B R regulates leukocyte recruitment and whether this affects inflammation remains to be elucidated. Endothelin-1 has been shown to promote neutrophil recruitment via TNF-α and CXCL1/CXCR2 in mice, which is mediated by both ET A R and ET B R [39] . Because ECs are known to be the major source of ET-1 under physiological conditions [40] , it is conceivable that ET-1 may be responsible for the influence of ET B R on leukocyte recruitment [41] . However, a major role of ET-1 in leukocyte recruitment in HCMV-infected HUVECs is unlikely since we observed that HCMV downregulates both ET-1 mRNA and protein levels (unpublished data), whereas HCMV may use ET B R for other purposes during infection.
We detected ET B R in ECs, SMCs, and macrophages/foam cells, which is consistent with previously reported data of increased ET B R immunoreactivity in human atherosclerotic lesions [42, 43] . Consistent with these studies and the new data presented here, we observed that HCMV-positive cells in atherosclerotic plaques exhibited intense ET B R staining, mainly in ECs and SMCs. Although all of the examined carotid plaques showed high prevalence of both HCMV-IE antigens (80%) and ET B R (80%), the majority of them was graded I (62.5% for both antigens in their positive staining, respectively). These observations demonstrate a close association between HCMV and ET B R in human atherosclerotic plaques, but the functional relevance of this observation will require further studies. In this study, only 1 case had abundant ET B R (graded III) expression (Supplementary Table S1 ); this makes the direct correlation between HCMV-IE antigens and ET B R difficult to assess. Moreover, HCMV infection is known to produce a myriad of indirect effects such as enhanced expression of adhesion molecules, induced production of proinflammatory cytokines, and activation of T cells, which may also contribute to atherosclerosis [3] .
In this study, we also found that although the expression of ET B R in vitro is predominantly cytoplasmic or perinuclear upon HCMV infection, its expression is localized to nucleus in ex vivo carotid plaques. The similar dominant nuclear localization in cardiac myocytes has been reported previously [44] , and recently it was proposed that the endothelin receptors of the nuclear membrane may play an important role in ET-1 action by receiving the ET-1 receptor-mediated cytosolic signaling [45] . In the context of virus infection, we speculate that the nuclear localization of ET B R that occurs upon HCMV infection may facilitate virus replication, and this hypothesis is under investigation in our laboratory.
We found that HCMV infection renders ECs refractory to migration and blunts their capacity to form tubes. Our finding is in line with Yamamoto-Tabata et al [46] , who used the same virus strain and cells but in contrast with another study that used different virus strain appended with enhanced green fluorescent protein and microvascular ECs [47] . Endothelial cells from different vascular beds are known to respond differently to HCMV infection [48] . In a recent study, we provided multifaceted evidence that direct infection with HCMV strain VR1814 induces an antimigratory and antiangiogenic ECs phenotype that could have detrimental effects on the vasculature development (unpublished data). The antiangiogenic properties conferred by HCMV may also pose a threat to therapeutic angiogenesis. On the other hand, both HCMV-encoded pUL7 protein and/or its major secretome, interleukin-6, were shown to promote angiogenesis [49, 50] . Thus, it appears that HCMV-infected cells are antiangiogenic whereas its secretome is proangiogenic.
Our present study is limited by lack of an appropriate in vivo model because HCMV is highly species-specific and does not efficiently infect or cause any apparent disease in animals. Therefore, it is difficult to delineate the net effects of HCMV infection on endothelin receptors and thereby provide a better understanding of the molecular mechanisms by which HCMV may promote atherosclerosis through regulation of ET B R expression.
CONCLUSIONS
In conclusion, our data suggest that HCMV is capable of inducing ET B R expression, and close association between HCMV and ET B R in human atherosclerotic plaques may suggest a role in atherogenesis that requires further investigation. Moreover, our finding that direct HCMV infection is antiangiogenic highlights the need to consider the presence of this pathogen in therapeutic angiogenesis.
